Applied Molecular Transport Inc.
AMTIDelisted Dec 28, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801777
Applied Molecular Transport Inc. was delisted on Dec 28, 2023; its insiders filed their last Form 4 on Dec 29, 2023; 27 institutions reported holding it in 13F filings for Q3 2023, worth $2.44M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 27
- Q3 2023, −2 vs. previous quarter
- 13F value
- $2.44M
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- –
- No comparable prior period
- Net income, FY2022
- -$126.3M
- No comparable prior period
- Free cash flow, FY2022
- -$98.1M
- No comparable prior period
- Revenue, Q3 FY2023
- –
- No comparable prior period
Superinvestors holding AMTI, Q3 2023
Go to the superinvestors tabNo superinvestor reported holding AMTI at the end of Q3 2023.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Applied Molecular Transport Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2023 (view filing)4:52 PM ET | Nov 22 | 5 days | Mahmood Tahir Ph.D.Director | SSale | −286.3K | $0.1634 | −$46.8K | −37.1%484.7K after | |
| Nov 27, 2023 (view filing)4:47 PM ET | Nov 22 | 5 days | Hants BrandonCFO | SSale | −61.5K | $0.1635 | −$10.1K | −17.0%301.2K after | |
| Nov 24, 2023 (view filing)4:21 PM ET | Nov 22 | 2 days | Cross ShawnCEO & Chair of the Board | SSale | −110.8K | $0.1635 | −$18.1K | −16.9%545.5K after | |
| Nov 16, 2023 (view filing)5:38 PM ET | Nov 15 | 1 day | Hants BrandonCFO | SSale | −50.1K | $0.1606 | −$8.05K | −12.1%362.7K after | |
| Nov 16, 2023 (view filing)5:36 PM ET | Nov 15 | 1 day | Cross ShawnCEO & Chair of the Board | SSale | −90.4K | $0.1606 | −$14.5K | −12.1%656.3K after | |
| Oct 10, 2023 (view filing)5:02 PM ET | Oct 6 | 4 days | Mahmood Tahir Ph.D.Director | SSale | −184.4K | $0.1647 | −$30.4K | −19.3%771.1K after | |
| Oct 4, 2023 (view filing)7:30 PM ET | Jun 2-Sep 5 | 124 daysLate | Mahmood Tahir Ph.D.Director | SSale | −4.24K | $0.2234 | −$946.51 | −5.8%69.4K after | 2 lots |
| Oct 4, 2023 (view filing)7:28 PM ET | Jun 2-Sep 5 | 124 daysLate | Hants BrandonCFO | SSale | −2.92K | $0.2327 | −$679.68 | −0.7%412.9K after | 3 lots |
| Oct 4, 2023 (view filing)7:27 PM ET | Jun 2-Sep 5 | 124 daysLate | Cross ShawnCEO & Chair of the Board | SSale | −5.56K | $0.2334 | −$1.30K | −0.7%746.7K after | 4 lots |
| Oct 2, 2023 (view filing)7:10 PM ET | Sep 29 | 3 days | Hants BrandonCFO | SSale | −107.5K | $0.1585 | −$17.0K | −20.5%415.8K after |
Top 10 13F holders, Q3 2023
See all 27 holdersThe largest institutional positions in Applied Molecular Transport Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC | 8,689,075 | $1.36M | 0.74% | −5,189−0.1% | Reduced |
| Founders Fund V Management, LLC | 3,611,615 | $567.0K | 70.62% | 00.0% | Unchanged |
| Vanguard Group Inc | 866,392 | $136.0K | 0.00% | −483,475−35.8% | Reduced |
| Founders Fund VI Management, LLC | 826,607 | $129.8K | 0.98% | 00.0% | Unchanged |
| BlackRock Inc. | 456,409 | $71.7K | 0.00% | −48,426−9.6% | Reduced |
| Renaissance Technologies LLC | 282,187 | $44.0K | 0.00% | +8,900+3.3% | Added |
| Laurion Capital Management LP | 217,828 | $34.2K | 0.00% | −169,555−43.8% | Reduced |
| Geode Capital Management, LLC | 139,808 | $21.9K | 0.00% | −3,801−2.6% | Reduced |
| HRT Financial LP | 113,307 | $17.0K | 0.00% | +113,307 | New |
| Wealth Enhancement Advisory Services, LLC | 66,207 | $10.4K | 0.00% | +66,207 | New |